DARPA scientists at the US Department of Defense (DoD) have determined that an antibiotic and a protein are capable of fighting radiation sickness more effectively when combined.
The Defense Advanced Research Projects Agency - aka DARPA - wants to replace outdated antibiotics with nanoparticles capable of targeting unknown, evolving and genetically engineered bioweapons.
